Silexion Therapeutics Corp
Silexion Therapeutics develops siRNA therapeutics targeting KRAS-mutant solid tumors.
8-KNov 16Latest SEC filing
Nov 16Latest story
November 2026
October 2026
September 2026
August 2026
July 2026
Silexion Therapeutics develops siRNA therapeutics targeting KRAS-mutant solid tumors.
November 2026
October 2026
September 2026
August 2026
July 2026